secwatch.observer — SEC 8-K summary
======================================

Issuer:     Quoin Pharmaceuticals, Ltd. (QNRX)
CIK:        0001671502
Form:       8-K
Filed at:   2025-11-17T23:59:59+00:00
Accession:  0001104659-25-113237
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Quoin Pharmaceuticals approves stock option award agreement forms under 2025 Equity Plan
--------------------------------------------------------------------------------

- Compensation Committee approved forms of Incentive and Non-Qualified Stock Option Award Agreements on Nov 14, 2025.
- Awards are governed by the 2025 Equity Incentive Plan; exercise price can be paid via cash, broker-assisted sales, or cashless exercise.
- Unvested options terminate upon employment cessation; vested options exercisable for up to 1 year after death/disability or 3 months after other termination.
- All awards subject to clawback policy as per Plan Section 16.6; forfeited shares subject to transfer powers.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671502/000110465925113237/0001104659-25-113237-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671502/000110465925113237/tm2531454d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-113237

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer